Green Cross Health Ltd
NZX:GXH
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
NZ |
Green Cross Health Ltd
NZX:GXH
|
142m NZD | 5.1 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
75B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
29.3B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
13.8B USD | 11 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
44.5B BRL | 21.9 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
46.3B CNY | 23.7 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
937.3B JPY | 10.8 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
83.1B MXN | 9.4 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.3B SAR | 18 | ||
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
510.2B JPY | 15.8 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
23.4B CNY | 17.7 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.